These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 30973809)

  • 21. Chronic heart failure and type 2 diabetes mellitus: The last battle?
    Kearney MT
    Diab Vasc Dis Res; 2015 Jul; 12(4):226-7. PubMed ID: 26099813
    [No Abstract]   [Full Text] [Related]  

  • 22. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure.
    Mørk HK; Sjaastad I; Sande JB; Periasamy M; Sejersted OM; Louch WE
    J Mol Cell Cardiol; 2007 Aug; 43(2):177-86. PubMed ID: 17574269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Decreased expression of calcium-sensing receptor involved in the progression of diabetic cardiomyopathy].
    Jia Z; Sun J; Li HZ; Li HX; Peng X; Shao HJ; Yang JX; Xu CQ; Bai SZ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Jan; 31(1):35-7. PubMed ID: 26016235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy.
    Asrih M; Steffens S
    Cardiovasc Pathol; 2013; 22(2):117-25. PubMed ID: 22951386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus gene transfer of SERCA in heart failure. A promising therapeutic approach ?
    Baartscheer A
    Cardiovasc Res; 2001 Feb; 49(2):249-52. PubMed ID: 11164834
    [No Abstract]   [Full Text] [Related]  

  • 27. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
    Russell J; Du Toit EF; Peart JN; Patel HH; Headrick JP
    Cardiovasc Diabetol; 2017 Dec; 16(1):155. PubMed ID: 29202762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of diabetic cardiomyopathy.
    Bugger H; Abel ED
    Diabetologia; 2014 Apr; 57(4):660-71. PubMed ID: 24477973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
    Ansari M; Gopalakrishnan S; Kurian GA
    J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diabetic cardiomyopathy.
    Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
    Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction.
    Hassoun SM; Marechal X; Montaigne D; Bouazza Y; Decoster B; Lancel S; Neviere R
    Crit Care Med; 2008 Sep; 36(9):2590-6. PubMed ID: 18679108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial Dysfunction after Severe Food Restriction Is Linked to Changes in the Calcium-Handling Properties in Rats.
    Deus AF; Silva VLD; de Souza SLB; Mota GAF; Sant'Ana PG; Vileigas DF; Lima-Leopoldo AP; Leopoldo AS; Campos DHS; de Tomasi LC; Padovani CR; Kolwicz SC; Cicogna AC
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
    Hoshijima M; Knöll R; Pashmforoush M; Chien KR
    J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A needle in a haystack: focus on "Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart".
    Davidson SM
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R183-5. PubMed ID: 21123761
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes.
    Kralik PM; Ye G; Metreveli NS; Shem X; Epstein PN
    Cardiovasc Toxicol; 2005; 5(3):285-92. PubMed ID: 16244373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of reduced contractility in an animal model of hypertensive heart failure.
    Ward ML; Crossman DJ; Cannell MB
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):711-6. PubMed ID: 21711381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium signaling in diabetic cardiomyocytes.
    Pereira L; Ruiz-Hurtado G; Rueda A; Mercadier JJ; Benitah JP; Gómez AM
    Cell Calcium; 2014 Nov; 56(5):372-80. PubMed ID: 25205537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.
    Bayeva M; Sawicki KT; Ardehali H
    J Am Heart Assoc; 2013 Nov; 2(6):e000433. PubMed ID: 24275630
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitochondrial dysfunction in diabetic cardiomyopathy.
    Duncan JG
    Biochim Biophys Acta; 2011 Jul; 1813(7):1351-9. PubMed ID: 21256163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MICU1 Alleviates Diabetic Cardiomyopathy Through Mitochondrial Ca
    Ji L; Liu F; Jing Z; Huang Q; Zhao Y; Cao H; Li J; Yin C; Xing J; Li F
    Diabetes; 2017 Jun; 66(6):1586-1600. PubMed ID: 28292968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.